Table 2 SpA subtypes, cut-off points, questionnaires and outcomes included in the systematic review and meta-analyses
From: The prevalence of sarcopenia in spondyloarthritis patients: a meta-analysis
Study | SpA subtypes | Classification used | Assessment method for muscle mass | Correction method for muscle mass | Cut-off points muscle mass | Cut-off points grip strength | Cut-off points gait speed | Questionnaires | Time of follow up | Interventions | Outcomes | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | Men | Women | |||||||||
Aguiar 2014 [14] | AS, PsA | Lee’s equation | Measuring Tape and Skinfold Caliper | Sex, Age, and Ethnicity | < 10.75 kg/m2 | < 6.75 kg/m2 | NA | NA | NA | NA | HAQ | NA | NA | Ultrasound can diagnosis sarcopenia in spondyloarthritis |
Barone 2018 [15] | AS, PsA | EWGSOP for sarcopenia Other for presarcopenia | BIA 101 | Height | < 10.75 kg/m2 | < 6.75 kg/m2 | < 30 kg | < 20 kg | NA | NA | NA | NA | NA | NA |
Barros 2012 [16] | active AS | Baumgartner | DXA | Height | < 7.26 kg/m2 | < 5.45 kg/m2 | NA | NA | NA | NA | ASQoL | 6 m, 12 m, 24 m | Anti-TNF | Sarcopenia reversion (BL: 16.6% vs. 6 m: 13.3% vs. 12 m: 6.6% vs. 24 m: 0%, p < 0.001) |
Fitzgerald 2017 [17] | axSpA | Other | BIA | Height | < 8.87 kg/m2 | < 6.42 kg/m2 | NA | NA | NA | NA | ASQoL | NA | NA | NA |
Kavadichanda 2022 [18] | SpA, PsA | AWGS | DXA | Height | < 7.0 kg/m2 | < 5.4 kg/m2 | NA | NA | NA | NA | NA | NA | NA | NA |
Krajewska 2017 [19] | PsA | EWGSOP | BIA (InBody170) | Height | NA | < 5.45 kg/m2 | NA | NA | NA | NA | NA | NA | NA | NA |
Leite 2020 [20] | PsA | Other | DXA | Height | NA | NA | NA | NA | NA | NA | HAQ | NA | NA | NA |
Maghraoui 2016 [21] | AS | EWGSOP for sarcopenia Baumgartner for presarcopenia | DXA | Height | < 7.25 kg/m2 | NA | < 30 kg | NA | Timed get-up-and-go test > 10s | NA | NA | NA | NA | NA |
Merle 2023 [2] | SpA | EWGSOP2 | DXA | Height | < 7.0 kg/m2 | < 5.5 kg/m2 | < 27 kg | < 16 kg | ≤ 0.8 m/s | ≤ 0.8 m/s | SarQoL® | NA | NA | NA |
Neto 2022 [22] | axSpA | EWGSOP2 | BIA (InBody770) | Height | < 7.0 kg/m2 | < 6 kg/m2 | < 27 kg | < 16 kg | ≤ 0.8 m/s | ≤ 0.8 m/s | IPAQ | NA | NA | NA |
Paccou 2020 [23] | active PsA | Baumgartner | DXA | Height | < 7.26 kg/m2 | < 5.5 kg/m2 | NA | NA | NA | NA | NA | 6 m | Ustekinumab | Total lean mass decreased |
Sequeira 2013 [24] | SpA | Lee’s equation | Measuring Tape and Skinfold Caliper | Sex, Age, and Ethnicity | NA | NA | NA | NA | NA | NA | HAQ | NA | NA | NA |
Song 2017 [25] | AS | AWGS Korea criteria | DXA | Height | < 7.0 kg/m2 NA | < 5.4 kg/m2 NA | < 28 kg NA | < 18 kg NA | < 1.0 m/s NA | < 1.0 m/s NA | NA | NA | NA | NA |
Soto 2023 [26] | SpA | ASMM | DXA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Tournadre 2017 [27] | SpA, PsA | EWGSOP | DXA | Height | < 7.26 kg/m2 | < 5.45 kg/m2 | NA | NA | NA | NA | HAQ | NA | NA | NA |
Younis 2021 [28] | AS | EWGSOP | DXA | Height | < 7.0 kg/m2 | < 6 kg/m2 | < 27 kg | < 16 kg | ≤ 0.8 m/s | ≤ 0.8 m/s | GPPAQ | NA | NA | NA |